CD4+CD25+Foxp3+ regulatory T (Treg) cells exerted the therapeutic potential by facilitating the repair process and reduced proinflammatory cytokine production by other T cell subsets in AKI [22]. This evidence concerns the gene CD4 and acute kidney injury.